From the Department of Radiology & Biomedical Imaging, Division of Interventional Neuroradiology (K.H.N., B.F.K., D.M., A.C., J.M., M.R.A., C.F.D., V.V.H., R.T.H., T.M., M.W.W., D.L.C., S.W.H.), and Department of Neurology (J.V., C.H.S.), University of California San Francisco, 505 Parnassus Ave, L-351, San Francisco, CA 94143-0628; and Siemens Medical Solutions, Malvern, Pa (K.M., H.B.).
Radiology. 2021 Apr;299(1):167-176. doi: 10.1148/radiol.2021202750. Epub 2021 Feb 9.
Background For patients with acute ischemic stroke undergoing endovascular mechanical thrombectomy with x-ray angiography, the use of adjuncts to maintain vessel patency, such as stents or antiplatelet medications, can increase risk of periprocedural complications. Criteria for using these adjuncts are not well defined. Purpose To evaluate use of MRI to guide critical decision making by using a combined biplane x-ray neuroangiography 3.0-T MRI suite during acute ischemic stroke intervention. Materials and Methods This retrospective observational study evaluated consecutive patients undergoing endovascular intervention for acute ischemic stroke between July 2019 and May 2020 who underwent either angiography with MRI or angiography alone. Cerebral tissue viability was assessed by using MRI as the reference standard. For statistical analysis, Fisher exact test and Student test were used to compare groups. Results Of 47 patients undergoing acute stroke intervention, 12 patients (median age, 69 years; interquartile range, 60-77 years; nine men) underwent x-ray angiography with MRI whereas the remaining 35 patients (median age, 80 years; interquartile range, 68-86 years; 22 men) underwent angiography alone. MRI results influenced clinical decision making in one of three ways: whether or not to perform initial or additional mechanical thrombectomy, whether or not to place an intracranial stent, and administration of antithrombotic or blood pressure medications. In this initial experience, decision making during endovascular acute stroke intervention in the combined angiography-MRI suite was better informed at MRI, such that therapy was guided in real time by the viability of the at-risk cerebral tissue. Conclusion Integrating intraprocedural 3.0-T MRI into acute ischemic stroke treatment was feasible and guided decisions of whether or not to continue thrombectomy, to place stents, or to administer antithrombotic medication or provide blood pressure medications. © RSNA, 2021 See also the editorial by Lev and Leslie-Mazwi in this issue.
背景 对于接受 X 射线血管造影的急性缺血性脑卒中患者,使用支架或抗血小板药物等辅助手段来维持血管通畅可能会增加围手术期并发症的风险。目前尚不清楚使用这些辅助手段的标准。目的 评估在急性缺血性脑卒中介入治疗中使用双联 X 射线神经血管造影 3.0-T MRI 套件进行 MRI 引导的关键决策。材料与方法 本回顾性观察性研究纳入了 2019 年 7 月至 2020 年 5 月期间接受血管内介入治疗的急性缺血性脑卒中患者,这些患者接受了 MRI 血管造影或单纯血管造影。以 MRI 为参考标准评估脑组织存活情况。采用 Fisher 确切检验和 Student t 检验对组间进行比较。结果 在 47 例接受急性脑卒中干预的患者中,12 例患者(中位年龄 69 岁;四分位距为 6077 岁;9 例男性)接受了 X 射线血管造影联合 MRI 检查,而其余 35 例患者(中位年龄 80 岁;四分位距为 6886 岁;22 例男性)仅接受了血管造影检查。MRI 结果以三种方式影响临床决策:是否进行初始或额外的机械取栓、是否放置颅内支架,以及使用抗血栓或降压药物。在这一初步经验中,在联合血管造影-MRI 套件中进行的急性缺血性脑卒中血管内治疗中,通过 MRI 实时指导,使治疗更具针对性。结论 将术中 3.0-T MRI 整合到急性缺血性脑卒中治疗中是可行的,可指导是否继续取栓、放置支架,或给予抗血栓药物或降压药物。